Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension

European Respiratory Journal

Volumn 45, Issue 1, 2015, Pages 139-149

  Courand, Pierre Yves ^a   Jomir, Géraldine Pina ^b   Khouatra, Chahéra ^b   Scheiber, Christian ^b   Turquier, Ségolène ^b   Glérant, Jean Charles ^b   Mastroianni, Bénédicte ^b   Gentil, Béatrice ^b   Blanchet Legens, Anne Sophie ^b   Dib, Alfred ^b,c   Derumeaux, Geneviève ^b   Humbert, Marc ^d,e,f   Mornex, Jean François ^b,c   Cordier, Jean François ^b,c   Cottin, Vincent ^b,c  

^a CROIX ROUSSE HOSPITAL   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e BICÊTRE HOSPITAL   (France)

^f CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; CALCIUM ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; PERTECHNETIC ACID TC 99M; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART OUTPUT; HEART RIGHT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLANAR EQUILIBRIUM RADIONUCLIDE ANGIOGRAPHY; PROGNOSIS; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SCINTIANGIOGRAPHY; SURVIVAL RATE; TREATMENT DURATION; AGED; ANGIOGRAPHY; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HYPERTENSION, PULMONARY; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PULMONARY ARTERY; REGISTER; TREATMENT OUTCOME;

ADULT; AGED; ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY ARTERY; REGISTRIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84920621357     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00158014     Document Type: Article

References (31)

1. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-1436.
2. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122: 156-163.
3. Vonk Noordegraaf A, Galiè N. The role of the right ventricle in pulmonary arterial hypertension. Eur Respir Rev 2011; 20: 243-253.
4. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115: 343-349.
5. van de Veerdonk MC, Kind T, Marcus JT, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011; 58: 2511-2519.
6. Vonk-Noordegraaf A, Westerhof N. Describing right ventricular function. Eur Respir J 2013; 41: 1419-1423.
7. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-1263.
8. Torbicki A. Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction. Eur Heart J 2007; 28: 1187-1189.
9. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007; 28: 1250-1257.
10. Nichols K, Saouaf R, Ababneh AA, et al. Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imaging. J Nucl Cardiol 2002; 9: 153-160.
11. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-1030.
12. Miller DP, Gomberg-Maitland M, Humbert M. Survivor bias and risk assessment. Eur Respir J 2012; 40: 530-532.
13. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: Suppl., S43-S54.
14. Sitbon O, Humbert M, Simonneau G. Les Traitements de l' hypertension artérielle pulmonaire a l' heure de la T2A. Recommandations du Groupe de Travail Maladies Vasculaires Pulmonaires de la Société de Pneumologie de langue Française [Treatment for pulmonary arterial hypertension under the new French hospital financing system. Recommendations of the Pulmonary Vascular Diseases Working Group of the French Society of Pulmonary Medicine]. Presse Med 2005; 34:1456-1464.
15. Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111: 3105-3111.
16. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
17. Groch MW, DePuey EG, Belzberg AC, et al. Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter study. J Nucl Med 2001; 42: 1773-1779.
18. Merabet Y, Bontemps L, Chevalier P, et al. Scintigraphic spectrum of a patient population with suspected arrhythmogenic right ventricular dysplasia. Int J Cardiovasc Imaging 2012; 28: 1267-1277.
19. Bontemps L, Merabet Y, Chevalier P, et al. Clinical validation of the planar radionuclide ventriculography in patients with right ventricular dysfunction. Rev Esp Med Nucl Imagen Mol 2013; 32: 364-370.
20. Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989; 80: 353-360.
21. Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006; 174: 1034-1041.
22. Nickel N, Golpon H, Greer M, et al. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2012; 39: 589-596.
23. Kawut SM, Horn EM, Berekashvili KK, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 2005; 95: 199-203.
24. Hemnes AR, Kawut SM. The right ventricle in pulmonary hypertension: from dogma to data. Am J Respir Crit Care Med 2010; 182: 586-588.
25. Han MK, Bach DS, Hagan PG, et al. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. Chest 2013; 143: 1699-1708.
26. Verdun FR, Bochud F, Gundinchet F, et al. Quality initiatives radiation risk: what you should know to tell your patient. Radiographics 2008; 28: 1807-1816.
27. Ernande L, Cottin V, Leroux PY Right isovolumic contraction velocity predicts survival in pulmonary hypertension. J Am Soc Echocardiogr 2013; 26: 297-306.
28. Gan C, Lankhaar JW, Marcus JT, et al. Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 2006; 290: H1528-H1533.
29. Schulman DS. Assessment of the right ventricle with radionuclide techniques. J Nucl Cardiol 1996; 3: 253-264.
30. Maddahi J, Berman DS, Matsuoka DT, et al. A new technique for assessing right ventricular ejection fraction using rapid multiple-gated equilibrium cardiac blood pool scintigraphy: description, validation and findings in chronic coronary artery disease. Circulation 1979; 60: 581-589.
31. Morrison D, Marshall J, Wright AI, et al. An improved method of right ventricular gated equilibrium blood pool radionuclide ventriculography. Chest 1982; 82: 607-614.